A message for our valued healthcare professionals:

If you are a returning registrant and wish to check your earned CME / CE credit history or print certificates for courses you have completed with ArcMesa Educators, we welcome you back and request that you please click here to access our login page.  If you are new to our site, we welcome you to join us and your colleagues who have already discovered the longest running, fully-accredited provider of CME / CE activities on the internet -- where we learn, share and teach. 

Thank you for making us part of a shared goal to improve patient care and quality of life!

-The ArcMesa Educators Team

Managing the Consequences of Multiple Sclerosis: A Multidisciplinary Approach to Improving the Quality of Life
Faculty: Francois Bethoux, MD | Susan E. Bennett, PT, EdD, NCS | Patricia Kennedy, RN, CNP, MSCN | Randall T. Schapiro, MD
CME Credit hour: 1.0
While there is no cure for Multiple Sclerosis, effective symptom management can greatly enhance quality of life. Long-term success is dependent on the early detection of symptoms and the development of a comprehensive care plan. This may be achieved with a combination of pharmacologic therapies, supportive services, and referral to specialists when necessary. In this program, our esteemed faculty discuss the benefits of a multidisciplinary care team consisting of neurologists, nurses, physiatrists, psychiatrists, physical therapists, occupational therapists, and speech therapists.

This program focuses on the signs and symptoms of multiple sclerosis, its affect on quality of life, and current pharmacologic and rehabilitation treatment options. The program also contains an interesting case study.

Osteoporosis: Opportunity for Better Outcomes
Faculty: Felicia Cosman, MD | Nelson B. Watts, MD | Michael R. McClung, MD | Kenneth W. Lyles, MD
CME credit hours: 2.0
Osteoporotic fractures affect millions of postmen-opausal women, and can have a substantial negative effect on daily functioning and quality of life. These fractures are associated with an increased risk of future fracture, clinical complications, and a higher risk of death. However, osteoporosis remains woefully under-diagnosed and undertreated, even among patients who already have fractures. When treatment is provided, adherence and persistence are often suboptimal, reducing the likelihood of a positive outcome.

Common Misconceptions With Bioequivalence & Interchangeability
Faculty: Andrew J. Pultz, Jr, PharmD, RPh | Joseph F. Dasta, MSc, FCCM, FCCP | Sandra L. Kane-Gill, PharmD, MSc
CE credit hour: 1.0
Bioequivalence is a comparison of two or more products with respect to their bioavailabilities. Bioequivalence of trade and generic products or different dosage forms of the same product needs to be determined before the products can be legally interchanged. Numerous factors can affect bioavailability (and bioequivalence) determinations. Thus, there is a great potential for wide variability among the pharmacokinetic profiles among patient populations and bioequivalence determinations. As pharmacists and Nurses, we are in an optimal position to prevent or intervene when a patient is experiencing drug-drug and drug-food interaction resulting in bioavailability alterations with outcomes including sub-therapeutic responses or adverse events. While product interchange between trade and generic medications or between dosage forms of the same product is typically not a problem this activity is going to highlight some examples of when it is a concern.

ACS Patients and Antiplatelet Resistance: Where We Are and Where We're Going.
Faculty: Deepak L. Bhatt, MD | Cindy L. Grines, MD | Peter B. Berger, MD
CME / CE credit hour: 1.5
Myocardial ischemia secondary to acute restrictions in coronary artery blood flow leads to acute coronary syndromes (ACS). Dual antiplatelet therapy with aspirin and clopidogrel is the standard of care for patients with ACS. However, resistance to these agents is associated with adverse clinical events, and is of great concern to clinicians. This educational program will review clinical data pertinent to the current state of antiplatelet therapy for the management of patients with ACS.

www.Arcmesa.org is dedicated to helping maintain and improve quality of life through medical education. All CME / CE activities are created in accordance with the latest industry policies and guidelines. From live symposia coverage to print monographs and CD ROMs, all our activities are free and available online at Arcmesa.org.

More >>>

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.